Stock & Company Details
Corbus Pharmaceuticals Holdings Inc $CRBP
Price:
N/A
N/A
19M
$102M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.85
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CRBP technical indicators
Latest Corbus Pharmaceuticals Holdings Inc (CRBP) indicator readings as of 2026-10-09.
CRBP's 14-day RSI is 23.3, in oversold territory. At $5.38 it is trading 39.6% below its 200-day moving average of $8.90, and below its 50-day average of $8.79. Price sits near the lower Bollinger Band ($5.07 to $8.48). ADX reads 49.8, indicating a trending market.
Overview
Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune systems. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Corbus' internal development pipeline includes CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells.
Finance Bot
Ask your questions
Start by typing a question below.
